Alamouti-Fard Emad, Garg Pankaj, Yazji John, Brigham Tara, Jacob Samuel, Wadiwala Ishaq J, Pham Si M
Cardiothoracic Surgery, Mayo Clinic, Jacksonville, FL, United States.
Mayo Clinic Libraries, Mayo Clinic, Jacksonville, FL, United States.
Front Cardiovasc Med. 2024 Sep 17;11:1414444. doi: 10.3389/fcvm.2024.1414444. eCollection 2024.
The number of patients living with left ventricular assist devices (LVADs) has gradually increased in the past decade. Non-cardiac surgery (NCS) in patients with LVAD poses a unique situation with its inherent challenges.
We conducted a comprehensive review to investigate the perioperative complications and mortality associated with emergent or elective NCS in patients with LVAD.
A comprehensive literature search for any papers referring to continuous LVAD patients with NCS. All publications with at least five durable LVAD patients who had NCS were eligible for inclusion.
Twenty articles matching our criteria were found and included in our study. This systematic review included 6,476 LVAD patients who underwent 6,824 NCS. There were 5-3,216 LVAD patients with NCS in each study. The median age was between 39 and 65 years, and most of the patients (78.8%) were male. Thirty-day postoperative mortality ranged from 0% to 60%. Eight studies reported no death within the 30 days of the operation. Common complications include gastrointestinal (GI) bleeding, intracranial bleeding, infection, acute kidney injury (AKI), urinary tract infection (UTI), stroke, sepsis, pneumonia, and VAD exchange. Emergent abdominal surgery had the highest (up to 60%) mortality rate, and vascular and neurological operations had the highest complication rates. Due to the diverse range of patients in each publication and the combination of outcomes presented in various publications, a meta-analysis was not conducted.
In LVAD patients, noncardiac surgery may be performed effectively and safely. LVAD patients who undergo non-cardiac surgery may require more transfusions due to their complex coagulopathies. However, perioperative management of LVAD patients undergoing emergent NCS should be optimized to reduce mortality.
在过去十年中,使用左心室辅助装置(LVAD)的患者数量逐渐增加。LVAD患者进行非心脏手术(NCS)带来了独特的情况及内在挑战。
我们进行了一项全面综述,以调查LVAD患者进行急诊或择期NCS的围手术期并发症及死亡率。
对任何提及持续使用LVAD的NCS患者的论文进行全面文献检索。所有至少有五例接受NCS的长期LVAD患者的出版物均符合纳入标准。
找到20篇符合我们标准的文章并纳入我们的研究。该系统综述纳入了6476例接受6824例NCS的LVAD患者。每项研究中有5 - 3216例LVAD患者接受了NCS。中位年龄在39至65岁之间,大多数患者(78.8%)为男性。术后30天死亡率在0%至60%之间。八项研究报告在手术30天内无死亡病例。常见并发症包括胃肠道(GI)出血、颅内出血、感染、急性肾损伤(AKI)、尿路感染(UTI)、中风、败血症、肺炎和VAD更换。急诊腹部手术的死亡率最高(高达60%),血管和神经手术的并发症发生率最高。由于各出版物中患者范围多样以及各出版物呈现的结果组合,未进行荟萃分析。
在LVAD患者中,非心脏手术可以有效且安全地进行。由于其复杂的凝血功能障碍,接受非心脏手术的LVAD患者可能需要更多输血。然而,应优化接受急诊NCS的LVAD患者的围手术期管理以降低死亡率。